Jasbir Seehra - CHIEF EXECUTIVE OFFICER, Director at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Stock Symbol
KROS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jasbir Seehra since 9/17/2023

Holdings reported by Jasbir Seehra for Keros Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 253K $11.5M $45.29 Apr 8, 2023 Direct
Employee Stock Option (right to buy) 125K Feb 23, 2024 Direct Common Stock

Transactions reported by Jasbir Seehra for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.